- Scientist & business leader
- 20+ years in Pharma/biotech industry
- Founding CEO & Director, Vigeo Therapeutics (clinical stage; oncology)
- Ex-Novartis, Tesaro and Alexion
- Proud program leader of two FDA approved oncology therapies: capmatinib and niraparib 🎉🎉
Invited by: Frank Wang
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
January 04, 2024 | 49 | +1 | +2.1% |
June 23, 2022 | 48 | -1 | -2.1% |
April 08, 2022 | 49 | +3 | +6.6% |
September 11, 2021 | 46 | +1 | +2.3% |